Testosterone Completed Phase 2 Trials for Hypogonadism / Low Testosterone Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01386567A One Year Open Label Study for the Treatment of Hypogonadism (Low Testosterone) in Men Who Have Completed ZA-203
NCT00975650Efficacy and Tolerability of an Intra-Nasal Testosterone Product
NCT01252745Efficacy of an Intranasal Testosterone Product
NCT02777242Safety of Subcutaneous Testosterone Enanthate in Adult Male Hypogonadism
NCT00452322Safety of Testosterone Undecanoate i.m. in Hypogonadal Men
NCT00647868NASOBOL in Hypogonadal Men in Comparison to Testosterone Levels in Normal Healthy Male Volunteers
NCT00857961A Study of the Pharmacokinetics of Testosterone Metered Dose (MD)-Lotion Formulations
NCT01323140Pharmacokinetics, Metabolism, Efficacy, and Safety Study of Two Testosterone Matrix Transdermal Systems
NCT01717768Oral Testosterone for the Treatment of Hypogonadism
NCT02222558Oral Testosterone for the Treatment of Hypogonadism in Males